TY - JOUR T1 - ULCERATIVE COLITIS-DERIVED COLONOID CULTURE: A Multi-Mineral-Approach to Improve Barrier Protein Expression JF - medRxiv DO - 10.1101/2019.12.12.19014662 SP - 2019.12.12.19014662 AU - Muhammad N Aslam AU - Shannon D McClintock AU - Durga Attili AU - Shailja Pandya AU - Humza Rehman AU - Daniyal M Nadeem AU - Mohamed Ali H Jawad-Makki AU - Areeba H Rizvi AU - Maliha M Berner AU - Michael K Dame AU - Danielle Kim Turgeon AU - James Varani Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/01/03/2019.12.12.19014662.abstract N2 - Background Recent studies demonstrated that Aquamin®, a calcium-, magnesium-, and multiple trace element-rich natural product, improves barrier structure and function in colonoids obtained from tissue of healthy subjects. The goal of the present study was to determine if the colonic barrier could be improved in tissue from subjects with ulcerative colitis (UC).Methods Colonoid cultures were established with tissue from 9 individuals with UC. The colonoids were then incubated for a 2-week period under control conditions (i.e., in culture medium with a final calcium concentration of 0.25 mM) or in the same medium supplemented with Aquamin® to provide 1.5 – 4.5 mM calcium. Effects on differentiation and barrier protein expression were determined using several approaches: phase-contrast & scanning electron microscopy, quantitative histology & immunohistology, mass spectrometry-based proteome assessment and transmission electron microscopy.Results Aquamin®-treated colonoids demonstrated a modest up-regulation of tight junctional proteins but stronger induction of adherens junction proteins and desmosomal proteins. Increased desmosomes were seen at the ultrastructural level. Proteomic analysis also demonstrated increased expression of basement membrane proteins and hemidesmosomal components. Proteins expressed at the apical surface (mucins and trefoils) were also increased as were several additional proteins with anti-microbial activity or that modulate inflammation.Conclusion A majority of individuals including patients with UC do not reach the recommended daily intake for calcium and other minerals. The findings presented here suggest that adequate mineral intake might improve the colonic barrier.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by National Institutes of Health (NIH) grant CA201782 including supplemental funding through the Office of Dietary Supplements to JV and by MCubed grant (University of Michigan) to MNA.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are fully available within the supplementary files.ABBREVIATIONSUCUlcerative colitisSEMScanning electron microscopyTEMTransmission electron microscopyTEERTrans-epithelial electrical resistanceTGFTransforming Growth FactorROCKRho-associated, coiled-coil containing protein kinaseEDTAEthylenediaminetetraacetic acidTRSTarget Retrieval SolutionHRPHorseradish peroxidaseFDRFalse discovery rateANOVAAnalysis of varianceSDStandard deviationCK20Cytokeratin 20CDH17Cadherin-17DSG2Desmoglein-2CEACAMCarcinoembryonic antigen-related cell adhesion moleculeSCFAShort-chain fatty acidsTNF-αTumor necrosis factor-alphaILInterleukinMCP-1Macrophage chemotactic peptide-1 ER -